高级检索
    饶南燕, 邵志敏, 王坤. 辅助化疗联合曲妥珠单抗显著提高人类表皮生长因子受体过表达乳腺癌的疗效[J]. 循证医学, 2006, 6(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2006.02.003
    引用本文: 饶南燕, 邵志敏, 王坤. 辅助化疗联合曲妥珠单抗显著提高人类表皮生长因子受体过表达乳腺癌的疗效[J]. 循证医学, 2006, 6(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2006.02.003
    shu
    RAO Nan-yan, SHAO Zhi-min, WANG Kun. Trastuzumab Plus Adjuvant Chemotherapy Improves Survival of Operable HER-2 Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2006.02.003
    Citation: RAO Nan-yan, SHAO Zhi-min, WANG Kun. Trastuzumab Plus Adjuvant Chemotherapy Improves Survival of Operable HER-2 Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2006.02.003
    shu

    辅助化疗联合曲妥珠单抗显著提高人类表皮生长因子受体过表达乳腺癌的疗效

    Trastuzumab Plus Adjuvant Chemotherapy Improves Survival of Operable HER-2 Positive Breast Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回